TABLE 1.
Serological analysis of samples from Sebeta to evaluate the extent of exposure to a number of potential parasites
| Virus or parasite | % Positive (no. positive/total no.):
|
||||
|---|---|---|---|---|---|
| Patients | Cured patients | Endemic controls | Healthy controls | Pa | |
| HIV | 4.0 (1/25) | 0.0 (0/27) | 5.9 (1/17) | 0.0 (0/18) | 0.503 (NSb) |
| Toxoplasma | 62.5 (15/24) | 74.1 (20/27) | 75.0 (9/12) | 56.3 (9/16) | 0.569 (NS) |
| Schistosoma | 0.0 (0/24) | 22.2 (6/27) | 0.0 (0/12) | 6.3 (1/16) | 0.022 |
| Plasmodium | 4.2 (1/24) | 3.7 (1/27) | 0.0 (0/12) | 0.0 (0/16) | 0.768 (NS) |
| Entamoeba | 29.2 (7/24) | 29.6 (8/27) | 16.7 (2/12) | 18.8 (3/16) | 0.731 (NS) |
| Giardia | 12.5 (3/24) | 3.7 (1/27) | 25.0 (3/12) | 12.5 (2/16) | 0.280 (NS) |
| Filaria | 33.3 (8/24) | 48.1 (13/27) | 58.3 (7/12) | 37.5 (6/16) | 0.465 (NS) |
| Echinococcus | 83.3 (20/24) | 85.3 (23/27) | 83.3 (10/12) | 43.8 (7/16) | 0.009 |
| Trichinella | 12.5 (3/24) | 18.5 (5/27) | 25.0 (3/12) | 12.5 (2/16) | 0.759 (NS) |
a
Groups were analyzed by chi-square analysis.
b
NS, not significant.